Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Electronics Production |

Cepheid acquires Sangtec for $27M

Cepheid a broad-based molecular diagnostics company has acquired Sangtec Molecular Diagnostics AB for about $27 million.

Sangtec is based in Bromma, Sweden, the company develops and manufactures PCR-based molecular diagnostics products. Sangtec has 59 employees and reported revenue in 2006 of about $8 million. Cepheid plans to integrate the Sangtec diagnostic kits targeted at the immunocompromised market into its existing European and U.S. portfolio of in vitro diagnostic products.

Ad
Ad
Load more news
March 28 2024 10:16 am V22.4.20-1
Ad
Ad